Arkolith/Insider Trading/VRCA/Form 4

Hayes Christopher G.

Chief Legal OfficerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Nov 16, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$99K
Net Open-Market Flow
-$99K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2023Sell(S)12K$2.97$34K123K
Nov 14, 2023Sell(S)22K$2.93$65K135K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-055527) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML